HIGHLIGHTS
- who: Report and colleagues from the Medical College Teaching Hospital, Kathmandu, NPL have published the article: Review began 05/20/2023 Review ended 05/29/2023 Published 06/01/2023 u00a9 Copyright, in the Journal: (JOURNAL) of June/01,/2023
- what: With the increasing use of amiodarone on both an inpatient and an outpatient basis, the advent of its multisystemic adverse effects is increasingly being reported.
SUMMARY
Amiodarone is a class III antiarrhythmic drug with high iodine content and structural similarity to thyroid hormones. Its mechanism of action can be attributed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.